Literature DB >> 26286531

Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.

Hannah Myles1, Nicholas Myles2, Matthew Large3.   

Abstract

OBJECTIVES: Cannabis use is prevalent among people with first episode psychosis and the epidemiology of its use in early psychosis is unclear. We performed a meta-analysis of observational studies to determine; (1) the interval between age at initiation of cannabis use and age at onset of first episode psychosis, (2) the prevalence of cannabis use at time of first episode psychosis, and (3) the odds of continuing cannabis following treatment for first episode psychosis. DATA SOURCES: Search of electronic databases MEDLINE, EMBASE, PsycINFO, Web of Science and CINAHL for English-language papers using search terms (psychosis OR schizophrenia) AND (cannabis OR marijuana) IN (title OR keyword OR abstract), current to October 2014. STUDY SELECTION: Studies were included if they reported on prevalence of current cannabis use in first episode psychosis cohorts. A total of 37 samples were included for meta-analysis. DATA EXTRACTION: Rates of cannabis use in each sample were extracted to determine prevalence estimates. The age at initiation of regular cannabis and age at onset of psychosis were used to determine the length of cannabis use preceding psychosis. Prevalence estimates at first episode psychosis and various time points of follow-up following first episode psychosis were analysed to determine odds ratio of continuing cannabis use. Data synthesis was performed using random-effects meta-analyses.
RESULTS: The pooled estimate for the interval between initiation of regular cannabis use and age at onset of psychosis was 6.3 years (10 samples, standardised mean difference = 1.56, 95% confidence interval = [1.40, 1.72]). The estimated prevalence of cannabis use at first episode psychosis was 33.7% (35 samples, 95% confidence interval = [31%, 39%]). Odds of continued cannabis use between 6 months and 10 years following first episode psychosis was 0.56 (19 samples, 95% confidence interval = [0.40, 0.79]). © The Royal Australian and New Zealand College of Psychiatrists 2015.

Entities:  

Keywords:  Cannabis; epidemiology; first episode; meta-analysis; psychosis

Mesh:

Year:  2015        PMID: 26286531     DOI: 10.1177/0004867415599846

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  30 in total

Review 1.  The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.

Authors:  Britta Hahn
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

2.  Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.

Authors:  Leslie Marino; Jennifer Scodes; Talia Richkin; Jean-Marie Alves-Bradford; Ilana Nossel; Melanie Wall; Lisa Dixon
Journal:  Schizophr Res       Date:  2020-05-28       Impact factor: 4.939

3.  First Presentation With Psychotic Symptoms in a Population-Based Sample.

Authors:  Gregory E Simon; Karen J Coleman; Bobbi Jo H Yarborough; Belinda Operskalski; Christine Stewart; Enid M Hunkeler; Frances Lynch; David Carrell; Arne Beck
Journal:  Psychiatr Serv       Date:  2017-01-03       Impact factor: 3.084

4.  The adverse health effects and harms related to marijuana use: an overview review.

Authors:  K Ally Memedovich; Laura E Dowsett; Eldon Spackman; Tom Noseworthy; Fiona Clement
Journal:  CMAJ Open       Date:  2018-08-16

5.  Care Pathways Before First Diagnosis of a Psychotic Disorder in Adolescents and Young Adults.

Authors:  Gregory E Simon; Christine Stewart; Enid M Hunkeler; Bobbi Jo Yarborough; Frances Lynch; Karen J Coleman; Arne Beck; Belinda H Operskalski; Robert B Penfold; David S Carrell
Journal:  Am J Psychiatry       Date:  2018-01-24       Impact factor: 18.112

6.  Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.

Authors:  Christian Núñez; Susana Ochoa; Elena Huerta-Ramos; Iris Baños; Ana Barajas; Montserrat Dolz; Bernardo Sánchez; Núria Del Cacho; Judith Usall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

7.  Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.

Authors:  Karl C Alcover; Oladunni Oluwoye; Liat Kriegel; Sterling McPherson; Michael G McDonell
Journal:  Schizophr Res       Date:  2019-08-02       Impact factor: 4.939

Review 8.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

9.  Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals.

Authors:  Luccas S Coutinho; Hianna Honorato; Cinthia H Higuchi; Daniel A Cavalcante; Sintia Belangeiro; Mariane Noto; Rodrigo A Bressan; Quirino Cordeiro; Cristiano Noto; Ary Gadelha
Journal:  Schizophr Res Cogn       Date:  2018-12-11

10.  Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.

Authors:  Laura Ferraro; Caterina La Cascia; Diego Quattrone; Lucia Sideli; Domenica Matranga; Veronica Capuccio; Giada Tripoli; Charlotte Gayer-Anderson; Craig Morgan; Musa B Sami; Pak Sham; Lieuwe de Haan; Eva Velthorst; Hannah E Jongsma; James B Kirkbride; Bart P F Rutten; Alexander L Richards; Laura Roldan; Celso Arango; Miquel Bernardo; Julio Bobes; Julio Sanjuan; Jose Luis Santos; Manuel Arrojo; Ilaria Tarricone; Andrea Tortelli; Andrei Szöke; Cristina Marta Del-Ben; Jean-Paul Selten; Michael Lynskey; Peter B Jones; Jim Van Os; Daniele La Barbera; Robin M Murray; Marta Di Forti
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.